Immunogen | IMGN - Ebitda



Ebitda تغيير تاريخ
AbbVie USD 5.37B 1.85B 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Amgen USD 5.14B 775M 2025-12
Astellas Pharma JPY 98.93B 84.75B 2026-03
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Exelixis USD 258.29M 15.43M 2026-03
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.84B 235M 2025-09
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 5.66B 3.77B 2025-09